A Study of FAZ053 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.
Novartis
Novartis
Sichuan Baili Pharmaceutical Co., Ltd.
Bavarian Nordic
ImmunityBio, Inc.
C4 Therapeutics, Inc.
NantCell, Inc.
Bavarian Nordic
BioMed Valley Discoveries, Inc
Novartis
Novartis